Literature DB >> 28967640

Endometrial stromal cells: isolation, expansion, morphological and functional properties.

A V Zlatska1, A E Rodnichenko1, O S Gubar2, D O Zubov3, S N Novikova3, R G Vasyliev3.   

Abstract

AIM: We aimed to study biological properties of human endometrial stromal cells in vitro.
MATERIALS AND METHODS: The endometrium samples (n = 5) were obtained by biopsy at the first phase of the menstrual cycle from women with endometrial hypoplasia. In all cases, a voluntary written informed consent was obtained from the patients. Endometrial fragments were dissociated by enzymatic treatment. The cells were cultured in DMEM/F12 supplemented with 10% FBS, 2 mМ L-glutamine and 1 ng/ml FGF-2 in a multi-gas incubator at 5% CO2 and 5% O2. At P3 the cells were subjected to immunophenotyping, multilineage differentiation, karyotype stability and colony forming efficiency. The cell secretome was assessed by BioRad Multiplex immunoassay kit.
RESULTS: Primary population of endometrial cells was heterogeneous and contained cells with fibroblast-like and epithelial-like morphology, but at P3 the majority of cell population had fibroblast-like morphology. The cells possessed typical for MSCs phenotype CD90+CD105+CD73+CD34-CD45-HLA-DR-. The cells also expressed CD140a, CD140b, CD146, and CD166 antigents; and were negative for CD106, CD184, CD271, and CD325. Cell doubling time was 29.6 ± 1.3 h. The cells were capable of directed osteogenic, adipogenic and chondrogenic differentiation. The cells showed 35.7% colony forming efficiency and a tendency to 3D spheroid formation. The GTG-banding assay confirmed the stability of eMSC karyotype during long-term culturing (up to P8). After 48 h incubation period in serum-free medium eMSC secreted anti-inflammatory IL-1ra, as well as IL-6, IL-8 and IFNγ, angiogenic factors VEGF, GM-CSF and FGF-2, chemokines IP-10 and MCP-1.
CONCLUSION: Thus, cultured endometrial stromal cells meet minimal ISCT criteria for MSC. Proliferative potential, karyotype stability, multilineage plasticity and secretome profile make eMSC an attractive object for the regenerative medicine use.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28967640

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  3 in total

Review 1.  Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review.

Authors:  Ilenia Mastrolia; Elisabetta Manuela Foppiani; Alba Murgia; Olivia Candini; Anna Valeria Samarelli; Giulia Grisendi; Elena Veronesi; Edwin M Horwitz; Massimo Dominici
Journal:  Stem Cells Transl Med       Date:  2019-07-16       Impact factor: 6.940

2.  Application of autologous endometrial mesenchymal stromal/stem cells increases thin endometrium receptivity: a case report.

Authors:  I M Sapozhak; О S Gubar; A E Rodnichenko; A V Zlatska
Journal:  J Med Case Rep       Date:  2020-10-17

Review 3.  Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications?

Authors:  Alicia Sanchez-Mata; Elena Gonzalez-Muñoz
Journal:  iScience       Date:  2021-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.